Press Releases

National Brain Tumor Society Broadens Expertise of Programs Group with Appointment of Pharmaceutical Industry Veteran Ann Kingston, PhD, brings more than two decades of experience in pharmaceutical research to leading brain tumor nonprofit January 28, 2014

AACR-National Brain Tumor Society 2013 Grant Announced Dr. Markus D. Siegelin, M.D. named the 2013 recipient of the AACR-National Brain Tumor Society Career Development Award for Translational Brain Tumor Research Earlier this week at the American Association for Cancer Research’s (AACR) Annual Meeting in Washington, D.C. (April 6-10, 2013) Dr. Markus D. Siegelin, M.D. was named the 2013 recipient of the AACR-National […] November 21, 2013

Advancing Research to Therapies for Brain Tumors Conference Connects Academic Scientists to Industry Investors National Brain Tumor Society’s inaugural event draws over 100 brain tumor researchers, biopharma executives, government officials, and venture capital investors National Brain Tumor Society, the largest nonprofit in the United States dedicated to the brain tumor community, recently hosted the inaugural Advancing Research to Therapies (ART) for Brain Tumors Conference in Washington, D.C. The ART […] November 21, 2013

Head to the Hill Advocacy Day Draws Hundreds to Capitol Hill to Speak-up for the Vital Needs of the Brain Tumor Community National Brain Tumor Society, the largest nonprofit dedicated to the brain tumor community in the United States, today held their annual “Head to the Hill” advocacy day in Washington, D.C. The event drew hundreds of brain tumor advocates from across the country to the nation’s capital to educate their respective congressional delegations on the critical […] November 21, 2013

National Brain Tumor Society 2013 Summit Celebrates Advances in Research and Policy, Honors Community Leaders National Brain Tumor Society, the largest nonprofit dedicated to the brain tumor community in the United States, hosted its 2013 Summit in Cambridge, MA, on October 3-6. The annual event brought together leaders from medical academia, the biotechnology and pharmaceutical industries, and nonprofit organizations, as well as patients, survivors, and families to highlight research and […] November 21, 2013